Update on the Swedish Newborn Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency

Congenital adrenal hyperplasia (CAH) was the fourth disorder added to the national Swedish neonatal screening program in 1986, and approximately 115,000 newborns are screened annually. Dried blood spot (DBS) screening with measurement of 17-hydroxyprogesterone (17OHP) is also offered to older childr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zetterström, Rolf H., Karlsson, Leif, Falhammar, Henrik, Lajic, Svetlana, Nordenström, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7570065/
https://www.ncbi.nlm.nih.gov/pubmed/33239597
http://dx.doi.org/10.3390/ijns6030071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7570065/
https://www.ncbi.nlm.nih.gov/pubmed/33239597
http://dx.doi.org/10.3390/ijns6030071

Ejemplares similares